AZ-EDGIO
22.2.2024 14:01:35 CET | Business Wire | Press release
Edgio (NASDAQ: EGIO), the platform of choice for speed, security, and simplicity at the edge, found that web application attacks continued to increase and evolve in the fourth quarter of 2023, as reported in its new Edgio Quarterly Attack Trends Report in which the company analyzed 5.2 billion attack requests. Edgio found that the most prevalent attack mitigated was path traversal. A successful path traversal attack allows a threat actor to access files on a web server, and has surpassed the prior #1 threat, SQL injection, a common attack vector that often uses malicious SQL statements to attempt to exfiltrate sensitive data from databases behind applications.
Edgio’s report explains how path traversal attacks can lead to deep system intrusions posing a significant threat to an organization’s infrastructure and the confidentiality, integrity, and availability of data delivered over the Internet. These attacks can result in unauthorized access to content, the loss of personally identifiable information (PII), the dissemination of private/copyrighted information, or even remote code execution. Unmitigated attacks can lead to even more serious consequences, such as the deployment of ransomware or other malicious software.
“As one of the leading edge-computing providers, Edgio has unparalleled visibility into the threats facing web applications today,” said Tom Gorup, Vice President of Security for Edgio. “We are assembling our knowledge and expertise into a quarterly read-out to enable enterprises to better protect their web infrastructure and applications. As more businesses become dependent on their digital assets, it’s critical this knowledge is shared to build a safer Internet.”
The report looked at malicious requests and the different types of blocking, categorizing protection into three categories: access control rules, managed rulesets, and custom signatures. Of those that were focused on access controls, over 76% of mitigated requests were based on IP, user-agent, and country matches, highlighting just how much bad traffic can be eliminated with basic blocklisting tactics. With managed rulesets, Edgio saw a wide range of threat types blocked, with path traversal, SQL injection and cross-site scripting (XSS) attacks leading the way when it comes to OWASP attacks.
In addition, Edgio was able to review web application firewall (WAF) request denials by country of origin, while noting that attackers often leverage local resources to launch attacks in order to evade geofencing tactics. This could explain why attacks coordinated from advanced threat actors in more prominent countries did not crack Edgio’s Top 10 for the quarter.
Top countries by malicious request origin, making up nearly 62% of all requests denied, include:
- United States – 26.3%
- France – 17.4%
- Germany – 9.4%
- Russia – 8.8%
Edgio found that WAF customers used access control features to allow or deny specific request methods, using their knowledge of their own applications to inform their security controls and lower risk. The report indicates that attackers frequently leverage request methods like HEAD that return app and infrastructure information that can be used by the attacker for reconnaissance purposes and to craft a malicious payload.
Based on deep parsing of attack payloads, Edgio found that 98% of all malicious payloads fell into JavaScript Object Notation (JSON) and URL encoded form categories (used for storing and transporting data) but cautioned security teams to remain vigilant as attackers evolve in their selection of payload content types.
Best practices for digital asset protection: proactively stop threats against websites and applications
Based on its findings, Edgio recommends the following methods to best protect digital assets, including websites and applications:
- Ensure your WAF provides a layered defense to protect organizations against the known bad, application-specific, and emerging threats. A complete solution will show a distribution of enforcement across access control rules, managed rulesets, and custom signatures.
- Blocklists are still an effective and low-cost part of a layered security approach to safeguard Internet-facing assets. Organizations should also take advantage of threat intelligence feeds to further harden their security posture against known bad actors.
- While managed rules are often maintained and updated by your WAF provider, it is not advisable to use a ‘set it and forget’ approach. As an application evolves and new functionalities are developed, policy reviews and analysis of managed ruleset enforcement is recommended. It is best to ensure rules are closely aligned with business application needs.
- Organizations should take the time to understand where they are doing business and where they aren’t allowed to do business. Block the countries or sub-regions that bring no value to a brand to reduce their attack surface. Blocking embargoed countries is a great starting point, but don’t rely on this approach as a catch all for bad actors.
- Know the application and use this knowledge to inform security solutions, like a WAF, to limit the application request methods or content types based on application needs.
To obtain a full copy of the report, click here.
About Edgio
Edgio (NASDAQCM: EGIO) helps companies deliver online experiences and content faster, safer and with more control. Our developer-friendly, globally scaled edge network, combined with our fully integrated application and media solutions, provides a single platform for delivering high-performing, secure web properties and streaming content. Companies can deliver content quicker and more securely through this fully integrated platform and end-to-end edge services, boosting overall revenue and business value. To learn more, visit edg.io and follow us on Twitter, LinkedIn and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222674952/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
